These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34132678)

  • 1. Breast Cancer Metastasis Mimicking Meningioma in 68Ga-DOTATOC PET/CT.
    Fabritius MP; Geyer T; Ahmaddy F; Albert NL; Bartenstein P; Tiling R; Rübenthaler J; Holzgreve A
    Clin Nucl Med; 2021 Nov; 46(11):922-923. PubMed ID: 34132678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 68Ga-DOTATOC PET/CT Differentiates Meningioma From Dural Metastases.
    Unterrainer M; Ruf V; Ilhan H; Vettermann FJ; Cyran CC; Niyazi M; Bartenstein P; Tonn JC; Albert NL
    Clin Nucl Med; 2019 May; 44(5):412-413. PubMed ID: 30829858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of 68Ga-DOTATOC PET/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy.
    Graf R; Nyuyki F; Steffen IG; Michel R; Fahdt D; Wust P; Brenner W; Budach V; Wurm R; Plotkin M
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):68-73. PubMed ID: 22575489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution.
    Acker G; Kluge A; Lukas M; Conti A; Pasemann D; Meinert F; Anh Nguyen PT; Jelgersma C; Loebel F; Budach V; Vajkoczy P; Furth C; Baur ADJ; Senger C
    Neurosurg Focus; 2019 Jun; 46(6):E9. PubMed ID: 31153151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience.
    Thorwarth D; Henke G; Müller AC; Reimold M; Beyer T; Boss A; Kolb A; Pichler B; Pfannenberg C
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):277-83. PubMed ID: 21300465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
    Milker-Zabel S; Zabel-du Bois A; Henze M; Huber P; Schulz-Ertner D; Hoess A; Haberkorn U; Debus J
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):222-7. PubMed ID: 16488553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
    Afshar-Oromieh A; Giesel FL; Linhart HG; Haberkorn U; Haufe S; Combs SE; Podlesek D; Eisenhut M; Kratochwil C
    Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1409-15. PubMed ID: 22669255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric 18F-FDG and 68GA-DOTATOC PET Imaging in Bone Metastatic Meningioma Before Radionuclide Therapy: Assessment of Tumor Heterogeneity.
    Mairal E; Chevalier E; Imbert L; Boursier-Joppin C; Verger A
    Clin Nucl Med; 2022 Mar; 47(3):e321-e322. PubMed ID: 35044963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of
    Stade F; Dittmar JO; Jäkel O; Kratochwil C; Haberkorn U; Debus J; Combs SE
    Radiat Oncol; 2018 Apr; 13(1):58. PubMed ID: 29606149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 68Ga-DOTATOC-PET/CT-guided resection of a primary intraosseous meningioma: technical note.
    Guinto-Nishimura GY; Gómez-Amador JL; Kerik-Rotenberg N; Uribe-Pacheco R; Sangrador-Deitos MV; Martínez-Manrique JJ
    Neurosurg Focus; 2021 Jan; 50(1):E6. PubMed ID: 33386007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy--a case series.
    Graf R; Plotkin M; Steffen IG; Wurm R; Wust P; Brenner W; Budach V; Badakhshi H
    Head Face Med; 2012 Jan; 8():1. PubMed ID: 22217329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pearls and Pitfalls in Interpretation of 68Ga-DOTATOC PET Imaging.
    Bashir A; Broholm H; Clasen-Linde E; Vestergaard MB; Law I
    Clin Nucl Med; 2020 Jun; 45(6):e279-e280. PubMed ID: 32332303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.
    Henze M; Schuhmacher J; Hipp P; Kowalski J; Becker DW; Doll J; Mäcke HR; Hofmann M; Debus J; Haberkorn U
    J Nucl Med; 2001 Jul; 42(7):1053-6. PubMed ID: 11438627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
    Iglseder S; Iglseder A; Beliveau V; Heugenhauser J; Gizewski ER; Kerschbaumer J; Stockhammer G; Uprimny C; Virgolini I; Dudas J; Nevinny-Stickel M; Nowosielski M; Scherfler C
    J Neurooncol; 2023 Sep; 164(3):711-720. PubMed ID: 37707754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 68Ga-DOTATOC PET in Extracranial Hepatic and Bone Metastasis of Atypical Refractory Meningioma: A Case Report.
    Ghomari CF; Bender L; Lhermitte B; Noël G; Namer IJ; Bund C
    Clin Nucl Med; 2023 Feb; 48(2):176-178. PubMed ID: 36607366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ⁶⁸Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results.
    Afshar-Oromieh A; Wolf MB; Kratochwil C; Giesel FL; Combs SE; Dimitrakopoulou-Strauss A; Gnirs R; Roethke MC; Schlemmer HP; Haberkorn U
    Neuro Oncol; 2015 Feb; 17(2):312-9. PubMed ID: 25008094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of [
    Milosevic A; Styczen H; Grueneisen J; Li Y; Weber M; Fendler WP; Kirchner J; Damman P; Wrede K; Lazaridis L; Glas M; Guberina M; Eckstein A; Blau T; Herrmann K; Umutlu L; Forsting M; Deuschl C; Schaarschmidt B
    J Nucl Med; 2023 Aug; 64(8):1185-1190. PubMed ID: 37385668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 68Ga-DOTA-peptide PET/CT for radiotherapy planning and evaluating treatment response in the management of meningiomas.
    Usmani S; Jain A; Hashmi SF; Mula-Hussain L; Riyami KA; Abubakar S; Shamim MS
    J Pak Med Assoc; 2023 Jun; 73(6):1340-1343. PubMed ID: 37427649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.
    Gehler B; Paulsen F; Oksüz MO; Hauser TK; Eschmann SM; Bares R; Pfannenberg C; Bamberg M; Bartenstein P; Belka C; Ganswindt U
    Radiat Oncol; 2009 Nov; 4():56. PubMed ID: 19922642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating dural metastases from meningioma: role of 68Ga DOTA-NOC PET/CT.
    Purandare NC; Puranik A; Shah S; Agrawal A; Gupta T; Moiyadi A; Shetty P; Shridhar E; Patil V; Rangarajan V
    Nucl Med Commun; 2020 Apr; 41(4):356-362. PubMed ID: 31939900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.